gtrx.com
About company
Grace Therapeutics is a pharmaceutical company with a focus on rare and orphan diseases. Grace's strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique evidence-based and outcomes-driven value proposition . ITs pipeline consists of three distinct assets all in late stage clinical development for the treatment of Postherpetic Neuralgia, Subarachnoid Hemorrhage, and Ataxia Telangiectasia. We intend to pursue multiple commercialization options for these products including their proprietary platform technologies for maximum value creation.
